, /PRNewswire/ -- InnoVoyce, a leading medical technology company, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the VYLOTM Laser System.
The VYLO Laser System is the first and only 455nm blue light laser to offer up to 30 watts of power and four emission modes. Intended for the surgical incision/excision, vaporization, ablation, hemostasis and coagulation of soft tissue including skin, cutaneous tissue, subcutaneous tissue, striated and smooth tissue, muscle, cartilage meniscus, mucous membrane, lymph vessels and nodes, organs and glands. The VYLO system is engineered to deliver a broad spectrum of surgical capabilities, enabling everything from the most delicate and precise cuts to the comprehensive removal of significant soft tissue masses with unmatched precision and control.
"InnoVoyce was established with a mission to introduce innovative solutions to treat the millions of individuals affected by voice disorders," said InnoVoyce CEO . "The FDA's clearance of the VYLO Laser System marks a significant milestone in our commitment to advancing healthcare with scalable laser technologies. This system is not only pivotal for vocal health but is also designed to effectively treat a variety of mucosal tissue conditions, highlighting its broad applications in medical treatment.
" The VYLO Laser System's versatility is demonstrated by its FDA clearance across multiple medical specialties, making it an invaluable tool for a wide a.
